SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-071378
Filing Date
2019-12-10
Accepted
2019-12-10 14:30:27
Documents
26
Period of Report
2019-12-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1924847d1_8k.htm 8-K 17859
2 EXHIBIT 99.1 tm1924847d1_ex99-1.htm EX-99.1 32772
3 GRAPHIC image_001.jpg GRAPHIC 40100
4 GRAPHIC image_002.jpg GRAPHIC 142811
5 GRAPHIC image_003.jpg GRAPHIC 47958
6 GRAPHIC image_004.jpg GRAPHIC 78402
7 GRAPHIC image_005.jpg GRAPHIC 118456
8 GRAPHIC image_006.jpg GRAPHIC 97561
9 GRAPHIC image_007.jpg GRAPHIC 93052
10 GRAPHIC image_008.jpg GRAPHIC 95722
11 GRAPHIC image_009.jpg GRAPHIC 97082
12 GRAPHIC image_010.jpg GRAPHIC 58055
13 GRAPHIC image_011.jpg GRAPHIC 83930
14 GRAPHIC image_012.jpg GRAPHIC 57001
15 GRAPHIC image_013.jpg GRAPHIC 87920
16 GRAPHIC image_014.jpg GRAPHIC 69102
17 GRAPHIC image_015.jpg GRAPHIC 105875
18 GRAPHIC image_016.jpg GRAPHIC 82136
19 GRAPHIC image_017.jpg GRAPHIC 56600
20 GRAPHIC image_018.jpg GRAPHIC 73692
21 GRAPHIC image_019.jpg GRAPHIC 83543
22 GRAPHIC image_020.jpg GRAPHIC 95844
23 GRAPHIC image_021.jpg GRAPHIC 73399
24 GRAPHIC image_022.jpg GRAPHIC 71650
25 GRAPHIC image_023.jpg GRAPHIC 49904
26 GRAPHIC image_024.jpg GRAPHIC 40100
  Complete submission text file 0001104659-19-071378.txt   2667699
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 191277335
SIC: 2836 Biological Products, (No Diagnostic Substances)